have been extensively studied, not much information is available about such findings for benign lesions [14] . Here, clinical, serological, and sonographic features of benign thyroid nodules with FDG uptake were retrospectively reviewed and compared with those without FDG uptake.
Patients and Methods

Patients
From May 2007 to May 2012, 37 patients underwent ultrasound (US) and other evaluations at the Division of Endocrinology and Metabolism, Hamamatsu University School of Medicine, for suspected nodules identified through whole-body cancer screening or staging using 18 F-FDG-PET/computed tomography (CT) or combined 18 F-FDG-PET and CT. Forty-eight consecutive thyroid lesions were evaluated, among them, 29 nodules with FDG uptake were aspirated using US-guided fine needle aspiration biopsy (FNAB); the results showed that 10 were malignant, 4 indeter-on the method reported by Shimura et al. [17] , with some modifications. The sonographic characteristics that were evaluated are as follows: shape (regular, intermediate, or irregular); margins (well-defined smooth, intermediate, or ill-defined jagged); texture (homogeneous, intermediate, or heterogeneous); level (isoechoic, hypoechoic, or marked hypoechoic); and presence of a fine strong echo (absent, intermediate, or present). Regarding the echo level, isoechoic or hypoechoic lesions were compared with the echogenicity of normal thyroid gland; marked hypoechogenecity was defined as a nodule that was hypoechoic compared with the surrounding strap muscles. The vascular pattern on CFD was classified as follows: a score of 1, absence of blood flow; a score of 2, perinodular blood flow; and a score of 3, intranodular blood flow [18] . Elasticity was scored as follows: 1 (high), 2 (intermediate), or 3 (low) [19] . Because RTE is less reliable for analyzing cystic nodules, nodules with >20% cystic content were scored as C [20] .
US-guided FNAB was performed using a 22-G needle and a 10-mL syringe and 2 passes were made per nodule. Pathologists examined samples obtained using FNAB.
Statistical analysis
Data were expressed as either as mean ± standard deviation (SD), numbers, or percentages. Differences between FDG-uptake-positive and FDG-uptakenegative groups were evaluated using unpaired t-test for continuous variables and Fisher's exact test or Mann-Whitney test for categorical variables. For FDG uptake, logistic regression analyses were performed to detect predictors with odds ratio before (univariate) and after (multivariate) adjustment with variables. All variables with a p-value <0.20 after univariate analysis and without collinearity between 2 variables were investigated using multivariate analysis. The statistical analyses were performed using IBM SPSS Statistics for Windows version 21 (IBM Software, Chicago, USA) and statistical significance was defined as p <0.05, with 2-sided p values. Table 1 summarizes the clinical and sonographic features of 32 benign nodules. None of the nodules had a fine strong echo. There were significant differences in the scores of both CFD (p = 0.012) and RTE minate, and 15 had benign cytology. Regarding the remaining 19 nodules showing non-avid FDG uptake, 2 nodules were excluded because they were located in a lobe with an FDG-avid lesion. Among the 17 nodules with non-avid FDG uptake, based on the FNAB in 11 nodules and the lack of suspicious sonographic findings of malignancy, such as micro-calcifications and/or intranodular hypervascularity [15] in 6 nodules, a diagnosis of benign lesions was made. Finally, the clinical, serological, and sonographic features of the 15 benign nodules with FDG uptake were retrospectively reviewed and compared with the 17 benign nodules without FDG uptake. The institutional review board approved this study, and neither informed consent nor patient approval was required for retrospective review of images and records (No. 24-126).
Results
Methods
Combined
18
F-FDG-PET and whole-body CT were performed at Hamamatsu Medical Imaging Center. F-FDG-PET has been described previously [16] . Focal uptake was visually categorized as positive by radiologists if the uptake was determined to be higher than that of the normal thyroid background. The standardized uptake value (SUV) was calculated as follows: SUV = FDG region / (FDG dose / WT), where the FDG region is the decay-corrected regional FDG concentration in Bq/mL, the FDG dose is the injected FDG in Bq, and WT is the body weight in grams. Maximum SUV (SUVmax) was defined as the SUV derived from the single voxel showing the highest uptake within a defined region of interest.
The serum thyroid stimulating hormone (TSH) concentrations were measured with the Elecsys platform (Roche Diagnostics K.K., Tokyo, Japan) and anti-thyroglobulin antibodies (TgAb) were measured with a commercial radioimmunoassay kit (Cosmic Co., Tokyo, Japan). Reference ranges used were as follows: TSH 0.5-5.0 μIU/mL and TgAb <0.3 U/mL.
Thyroid USs, including conventional B-mode imaging, color-flow Doppler (CFD), and real-time elastosonography (RTE), were performed using Hitachi EUB 8500 Logos equipment (Hitachi Medical Systems, Tokyo, Japan) by endocrinologists. Lesion size was measured at the greatest dimension of the nodule. Sonographic characteristics on B-mode imaging were evaluated using a 3-point scoring system based gender, TSH, TgAb, tumor size, and/or scoring for the 4 B-mode sonographic findings (i.e., shape, margin, texture, and echo level). Table 3 presents the results of logistic analyses. Before adjustment with characteristic variables, the vascular score of CFD and the elastic score of RTE were significant predictors of FDG uptake (p = 0.013 and 0.035, respectively). Multivariate analysis showed that the vascular score of CFD was the only independent and significant predictor of FDG uptake (p = 0.039).
(p = 0.036) between the nodules with and without FDG uptake (Table 2) . Of note, FDG uptake was associated with the intranodular blood flow (score 3; 40% vs. 0%, p = 0.006 by Fisher's exact test). With regard to the score of RTE, the presence of a cystic component (score C) was associated with a greater possibility of negative FDG uptake (0% vs. 35.3%, p = 0.019 by Fisher's exact test). After excluding score C, there was no significant difference in the elastic score. Table 2 also showed that the FDG-positive and -negative groups were not significantly different in terms of age, However, not much information has been reported on other factors related with FDG uptake. The clinical, serological, and sonographic features associated with benign thyroid nodules were analyzed compared with those of FDG uptake in the present study.
The results showed that the vascular score of CFD (p = 0.039) was the only independent factor that predicted FDG uptake (Table 3 ). Univariate analysis indicated that the presence of intranodular blood flow (score 3) was associated with a greater possibility of positive FDG uptake. In cases of extra-thyroid cancer, FDG uptake is closely linked to the rate of tumor blood flow [22, 23] . In addition, Kim et al. reported a high degree
Discussion
The focal accumulation of FDG is not specific to malignant thyroid nodules; benign nodules are reported in 60% -70% of such cases [2] [3] [4] . Across a wide range of tumor types, it is recognized that the extent of FDG uptake is positively correlated with several factors, including glucose transporter (GLUT) expression, tumor perfusion, viable cell number, and the presence of inflammatory cells [1] . Regarding benign thyroid nodules, Matsuzu et al. examined GLUT1 mRNA levels for nodular hyperplasia tissues and found no difference compared with that for normal thyroid tissue [21] . Gender (male/female) 6/9 6/11 1.000
TSH (μIU/L) 1.82 ± 1.30 1.62 ± 0.74 0.594
TgAb (Negative/Positive) 12/3 14/1 0.598
2)
Tumor size (mm) 16.3 ± 7.9 15.9 ± 7.2 0.884
Shape ( Real-time elastosonography (Score C/1/2/3) 0/3/11/1 6/2/9/0 0.036
3)
Variables were expressed as mean ± standard deviation or numbers. FDG represents fluorodeoxyglucose, TgAb represents anti-thyroglobulin antibodies, and TSH represents thyroid stimulating hormone, as determined using 1) unpaired t-test, 2) Fisher's exact test, and
3) Mann-Whitney test. the clinical significance of FDG-avidity in benign thyroid nodules has not been well characterized. In a previous report [16] , 6 patients with benign thyroid nodules were followed up with annual US and observed for a period of 3 years. One patient showed an increase in the nodule diameter, by more than 2-fold, during the follow-up period, whereas the other 5 patients exhibited negligible changes. As the number of patients in the previous study was very small, further studies are needed to elucidate whether benign FDG-avid nodules should be more carefully followed up compared with non-avid lesions.
This study has the following limitations. First, diagnoses of 6 nodules without FDG uptake did not have pathological evaluation (Table 1) . FNAB is not routinely recommended in patients with non-avid thyroid nodules at this center because many studies have reported that
18 F-FDG-PET provides a high negative predictive value for malignancies [11, 12] . Second,
18
F-FDG-PET examinations were performed at 3 different centers. The interpretation of the imaging studies may have been affected by methodological differences related with performing 18 F-FDG-PET (e.g., PET scanner, matrix size, number of iteration, and smoothing filter). Nevertheless, the findings of this study show that FDG uptake was correlated with increased vascularity in benign nodules.
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None of the authors have any potential conflicts of interest associated with this research. of expression of vascular endothelial growth factor in thyroid cancers incidentally detected using 18 F-FDG-PET [6] . These results appear to be compatible with the findings of this study, which asserts that a correlation exists between FDG uptake in benign thyroid nodules and increased vascularity on CFD.
RTE is a newly developed diagnostic tool used to evaluate the degree of distortion of the US beam in response to an external force, which allows for a semiquantitative determination of tissue elasticity [18] . Although univariate analysis revealed an association between the elastic score of RTE and FDG uptake (Table 2) , this association was explained by the presence of a cystic component rather than by the elasticity of the thyroid nodules. Because the number of viable cells is correlated with the extent of FDG uptake in a wide range of tumors [24] , it is plausible that cystic thyroid nodules are less probable to accumulate FDG.
Other specific factors that induce an increase in FDG accumulation in thyroid lesions include elevated serum TSH levels [25] , presence of Hürthle cells [5] , and concomitance of autoimmune thyroid disease [26] . In this study, the mean TSH values were similar in both the FDG-avid and the non-avid nodules. None of the FNAB examinations showed findings consistent with the presence of Hürthle cells. In contrast, a positive TgAb was more frequently observed in FDGavid nodules (20.0%) than in non-avid FDG nodules (6.7%), though the difference was not statistically significant. Because most autoimmune thyroid diseases are commonly associated with a diffuse, rather than a focal, FDG uptake pattern [26, 27] , additional cases are needed for statistical analysis of TgAb in nodules and focal FDG uptake.
Although it is well known that an increase in FDG uptake can reflect dedifferentiation across various cancer types, including metastatic thyroid carcinoma [28] ,
